143 related articles for article (PubMed ID: 9112136)
1. Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana.
Harder S; Rietbrock S
Int J Clin Pharmacol Ther; 1997 Apr; 35(4):155-9. PubMed ID: 9112136
[TBL] [Abstract][Full Text] [Related]
2. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana.
Weinstein A; Brickner O; Lerman H; Greemland M; Bloch M; Lester H; Chisin R; Sarne Y; Mechoulam R; Bar-Hamburger R; Freedman N; Even-Sapir E
J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724
[TBL] [Abstract][Full Text] [Related]
3. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment.
Ramaekers JG; Moeller MR; van Ruitenbeek P; Theunissen EL; Schneider E; Kauert G
Drug Alcohol Depend; 2006 Nov; 85(2):114-22. PubMed ID: 16723194
[TBL] [Abstract][Full Text] [Related]
4. Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs.
Azorlosa JL; Heishman SJ; Stitzer ML; Mahaffey JM
J Pharmacol Exp Ther; 1992 Apr; 261(1):114-22. PubMed ID: 1313866
[TBL] [Abstract][Full Text] [Related]
5. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
[TBL] [Abstract][Full Text] [Related]
6. [Cannabis affects driving skills].
Khiabani HZ; Christophersen AS; Mørland J
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):583-4. PubMed ID: 17332811
[TBL] [Abstract][Full Text] [Related]
7. The relationship between performance on the standardised field sobriety tests, driving performance and the level of Delta9-tetrahydrocannabinol (THC) in blood.
Papafotiou K; Carter JD; Stough C
Forensic Sci Int; 2005 Dec; 155(2-3):172-8. PubMed ID: 16226154
[TBL] [Abstract][Full Text] [Related]
8. Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans.
Hart CL; Ward AS; Haney M; Comer SD; Foltin RW; Fischman MW
Psychopharmacology (Berl); 2002 Dec; 164(4):407-15. PubMed ID: 12457271
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
[TBL] [Abstract][Full Text] [Related]
10. [Time profile of serum THC levels in occasional and chronic marihuana smokers after acute drog use - implication for drivind motor vehicles].
Balíková M; Hložek T; Páleníček T; Tylš F; Viktorinová M; Melicher T; Androvičová R; Tomíček P; Roman M; Horáček J
Soud Lek; 2014; 59(1):2-6. PubMed ID: 24625019
[TBL] [Abstract][Full Text] [Related]
11. Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.
Jones AW; Holmgren A; Kugelberg FC
Addiction; 2008 Mar; 103(3):452-61. PubMed ID: 18190663
[TBL] [Abstract][Full Text] [Related]
12. Impairment due to cannabis and ethanol: clinical signs and additive effects.
Bramness JG; Khiabani HZ; Mørland J
Addiction; 2010 Jun; 105(6):1080-7. PubMed ID: 20331551
[TBL] [Abstract][Full Text] [Related]
13. Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.
Strougo A; Zuurman L; Roy C; Pinquier JL; van Gerven JM; Cohen AF; Schoemaker RC
J Psychopharmacol; 2008 Sep; 22(7):717-26. PubMed ID: 18583433
[TBL] [Abstract][Full Text] [Related]
14. The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients.
Brenneisen R; Egli A; Elsohly MA; Henn V; Spiess Y
Int J Clin Pharmacol Ther; 1996 Oct; 34(10):446-52. PubMed ID: 8897084
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing marijuana self-administration by humans.
Haney M; Comer SD; Ward AS; Foltin RW; Fischman MW
Behav Pharmacol; 1997 Jun; 8(2-3):101-12. PubMed ID: 9833006
[TBL] [Abstract][Full Text] [Related]
16. Interaction between naltrexone and oral THC in heavy marijuana smokers.
Haney M; Bisaga A; Foltin RW
Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
[TBL] [Abstract][Full Text] [Related]
17. Marijuana carry-over effects on aircraft pilot performance.
Leirer VO; Yesavage JA; Morrow DG
Aviat Space Environ Med; 1991 Mar; 62(3):221-7. PubMed ID: 1849400
[TBL] [Abstract][Full Text] [Related]
18. Urinary elimination half-life of delta-1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson EK; Hollister LE; Halldin MM
NIDA Res Monogr; 1989; 95():457-8. PubMed ID: 2561839
[TBL] [Abstract][Full Text] [Related]
19. Effect of intrapulmonary tetrahydrocannabinol administration in humans.
Zuurman L; Roy C; Schoemaker RC; Hazekamp A; den Hartigh J; Bender JC; Verpoorte R; Pinquier JL; Cohen AF; van Gerven JM
J Psychopharmacol; 2008 Sep; 22(7):707-16. PubMed ID: 18515447
[TBL] [Abstract][Full Text] [Related]
20. [Serum cannabinoid levels 24 to 48 hours after cannabis smoking].
Skopp G; Richter B; Pötsch L
Arch Kriminol; 2003; 212(3-4):83-95. PubMed ID: 14639811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
